In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with Company's Code of Conduct for Prevention of Insider Trading and clarification issued by BSE vide its circular dated April 2, 2019 bearing no. LIST/COMP/01/2019-20, Kwality Pharmaceuticals has informed that the Trading Window for dealing in the Securities of the Company shall remain closed for all the Board of Directors, Designated Persons and their immediate relatives, with effect from Friday April 01st 2022 till 48 hour after declaration of the Audited Financial Results for the half year and year ended on March 31, 2022. The date of announcement of the Audited Financial Results for the Year ended 31st March, 2022 shall be intimated in due course of time.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1849.05 |
Dr. Reddys Lab | 1274.25 |
Cipla | 1553.20 |
Lupin | 2184.00 |
Zydus Lifesciences | 1001.85 |
View more.. |